> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Samsca Not Withdrawn for S&E
- URL: https://www.fdaweb.com/samsca-not-withdrawn-for-s-e/
- Published: 2016-08-02T12:00:00.000Z
- Updated: 2026-09-14T21:20:16.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136379

*Federal Register* Notice: FDA has determined that Samsca (tolvaptan) tablets, 60 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve abbreviated new drug applications (ANDAs) for tolvaptan tablets, 60 mg, if all other legal and regulatory requirements are met. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-08-02/pdf/2016-18139.pdf?ref=fdaweb.com)